MedCity Pivot Podcast: Should Testosterone Replacement Therapy Be Less Regulated?

February 22, 2026
, 2:46 pm

A VPN is an essential component of IT security, whether you’re just starting a business or are already up and running. Most business interactions and transactions happen online and VPN

Shalin Shah, CEO of Marius Pharmaceuticals, which makes an oral testosterone replacement drug, thinks TRT therapy should no longer be regulated as a controlled substance

The post MedCity Pivot Podcast: Should Testosterone Replacement Therapy Be Less Regulated? appeared first on MedCity News.

Leave a Replay

4 Health Tech Trends Startups Can’t Ignore, Per an Oak HC/FT Partner

Coral Care Raises $13M to Scale In-Home Pediatric Therapy

Headache Startup Slate Medicines Lands $130M to Bring Novel Migraine Drug Into the Clinic

Sign up for our Newsletter

HealthGility provides healthcare organizations with a solution for patient protected health information disclosure and confidentiality that reduces workloads and ensures the safe and secure sharing of sensitive data between different providers.

MedCity Pivot Podcast: Should Testosterone Replacement Therapy Be Less Regulated?

Leave a Replay

Related Posts

4 Health Tech Trends Startups Can’t Ignore, Per an Oak HC/FT Partner

Coral Care Raises $13M to Scale In-Home Pediatric Therapy

Headache Startup Slate Medicines Lands $130M to Bring Novel Migraine Drug Into the Clinic

Follow Us

Sign up for our Newsletter

Our Company

Resources

Connect

© All rights reserved

Contact Us